Page last updated: 2024-09-03

sdz nvi-085 and sk&f 89748

sdz nvi-085 has been researched along with sk&f 89748 in 1 studies

Compound Research Comparison

Studies (sdz nvi-085)	Trials (sdz nvi-085)	Recent Studies (post-2010) (sdz nvi-085)	Studies (sk&f 89748)	Trials (sk&f 89748)	Recent Studies (post-2010) (sk&f 89748)
10	1	0	16	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Apaydin, S; Saxena, PR; Van der Graaf, PH	1

Other Studies

1 other study(ies) available for sdz nvi-085 and sk&f 89748

Article	Year
The alpha 1-adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta. European journal of pharmacology, 1995, Dec-20, Volume: 287, Issue:3 Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Aorta, Thoracic; Binding, Competitive; Bridged-Ring Compounds; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oxazines; Rats; Rats, Wistar; Serotonin; Tetrahydronaphthalenes	1995

Article

Year

The alpha 1-adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta.

European journal of pharmacology, 1995, Dec-20, Volume: 287, Issue:3

Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Aorta, Thoracic; Binding, Competitive; Bridged-Ring Compounds; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oxazines; Rats; Rats, Wistar; Serotonin; Tetrahydronaphthalenes

1995